2° Preceptorship Translational Research in Urological Oncology Translational Medicine: A Bridge between Research and Therapy in Urogenital Cancers
-
Matteo Landriscina
- 44/40 Iscritti
- Medicina
- 1 Lezioni /1 Quiz
DATA SVOLGIMENTO: Data inizio: 26/11/2025 Data fine: 27/11/2025
DISCIPLINE ACCREDITATE:
Medico Chirurgo:
Oncologia, Genetica medica, Radioterapia, Urologia, Anatomia patologica, Patologia clinica (laboratorio di analisi), Radiodiagnostica. Biologo: Biologo. Farmacista: Farmacia ospedaliera, Medicina nucleare, Anestesia e rianimazione, Chirugia generale, Medicina Interna
Responsabile Scientifico Del Corso:
Dott.ssa Conteduca Vincenza,
Dott.Landriscina Matteo
PROGRAMMA SCIENTIFICO
Day 1 – 26th November 2025
10:30 Participant registration
10:45 Opening Remarks by Authorities
11:00 Introduction and Welcome
Giuseppe Carrieri, Vincenza Conteduca, Matteo Landriscina
Session 1: State-of-the-art of management of genitourinary cancers
Moderatori | Matteo Landriscina, Gian Maria Busetto
11:10 Urothelial cancer
Relatore | Vincenza Conteduca
11:40 Kidney cancer
Relatore | Matteo Landriscina
12:10 Prostate cancer
Relatore | Gian Maria Busetto
12:40 Discussion
13:00 Lunch
Session 2: integrating Clinical and Translational Research: Current e Future strategies
to Overcome Therapeutic Resistance
Moderatori | Giuseppe Carrieri, Elena Ranieri, Caterina Nardella
14:00 Master Lecture: Advances in prostate cancer therapy: emerging strategies and future perspectives
Relatore | Gert Attard
14:30 Identification of Genomic Biomarkers
Relatore | Vincenza Conteduca
15:00 Current and emerging challenges of Next-generation sequencing
Relatore | Daniel Wetterskog
15:30 Discussion
16:00 Roundtable discussion
All participants share their experience on molecular testing in the prostate cancer setting
17:00 Master Lecture: The potential role of Nanoparticles in GU tumours
Relatore | Donato Conteduca
17:30 Discussion
18:00 Conclusions
Responsabili Scientifici | Vincenza Conteduca, Matteo Landriscina
Day 2 – 27th November 2025
Session 1: A Journey into the Future of GU Cancer Research
Moderatori | Gert Attard, Caterina Nardella
09:00 Extracellular Vesicles: A new frontier in GU cancer liquid biopsy
Relatore | Lorenzo Messa
09:30 Implementing liquid biopsy in clinical trials
Relatore | Vincenza Conteduca
10:00 Discussion
10:30 Coffee break
Session 2: Lab Experience across Translation Research Units in Italy and Europe
Moderatori | Elena Ranieri, Vincenza Conteduca
11:00 The clinical and translational research activities at:
Relatori | Marianna Garofoli, Giuseppina Bruno
Prostate Translational Unit – University of Foggia, Italy
11:20 Department of Cellular, Computational and Integrative Biology, CIBIO – University of Trento, Italy
Relatore | Caterina Nardella
11:40 University College London Cancer Institute – London, UK
Relatore | Daniel Wetterskog
12:00 Discussion
13:00 Lunch
Session 3: From Research to Clinical Practice with a Translational Perspectives
Moderatori | Francesca Sanguedolce, Matteo Landriscina
14:00 Master Lecture: Germline testing and genetic counselling in prostate cancer
Relatore | Maria Iole Natalicchio
14:15 Clinical scenario 1: mCRPC patient with visceral metastases
Relatori | Stefania Sempreboni, Giuseppina Bruno
15:00 Clinical scenario 2: BRCA-mutated patient
Relatori | Giulia Villano, Valeria Bafunno
15:45 Discussion
16:15 Master Lecture: Integrating the PD-L1 Prognostic Biomarker in Urotelial and Kidney cancer
Relatore | Francesca Sanguedolce
16:45 Roundtable discussion
All participants share their experience on the current preceptorship
17:30 Take home messages
Responsabili Scientifici | Vincenza Conteduca, Matteo Landriscina
17:45 Test ECM
18:30 Conclusions
Responsabili Scientifici | Vincenza Conteduca, Matteo Landriscina